Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis
Latest Information Update: 19 Dec 2022
At a glance
- Drugs Baricitinib (Primary)
- Indications Uveitis
- Focus Therapeutic Use
- Acronyms JAKUVEITE
Most Recent Events
- 19 Dec 2022 New trial record